186 related articles for article (PubMed ID: 38512672)
1. Phosphorylation of Tau Protein by CDK2/cyclin A and GSK3β Recombinant Kinases: Analysis of Phosphorylation Patterns by Nuclear Magnetic Resonance Spectroscopy.
El Hajjar L; Bridot C; Nguyen M; Cantrelle FX; Landrieu I; Smet-Nocca C
Methods Mol Biol; 2024; 2754():271-306. PubMed ID: 38512672
[TBL] [Abstract][Full Text] [Related]
2. The Study of Posttranslational Modifications of Tau Protein by Nuclear Magnetic Resonance Spectroscopy: Phosphorylation of Tau Protein by ERK2 Recombinant Kinase and Rat Brain Extract, and Acetylation by Recombinant Creb-Binding Protein.
Qi H; Despres C; Prabakaran S; Cantrelle FX; Chambraud B; Gunawardena J; Lippens G; Smet-Nocca C; Landrieu I
Methods Mol Biol; 2017; 1523():179-213. PubMed ID: 27975251
[TBL] [Abstract][Full Text] [Related]
3. Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation.
Smet-Nocca C; Broncel M; Wieruszeski JM; Tokarski C; Hanoulle X; Leroy A; Landrieu I; Rolando C; Lippens G; Hackenberger CP
Mol Biosyst; 2011 May; 7(5):1420-9. PubMed ID: 21327254
[TBL] [Abstract][Full Text] [Related]
4. Structural characterization by nuclear magnetic resonance of the impact of phosphorylation in the proline-rich region of the disordered Tau protein.
Sibille N; Huvent I; Fauquant C; Verdegem D; Amniai L; Leroy A; Wieruszeski JM; Lippens G; Landrieu I
Proteins; 2012 Feb; 80(2):454-62. PubMed ID: 22072628
[TBL] [Abstract][Full Text] [Related]
5. Spectroscopic studies of GSK3{beta} phosphorylation of the neuronal tau protein and its interaction with the N-terminal domain of apolipoprotein E.
Leroy A; Landrieu I; Huvent I; Legrand D; Codeville B; Wieruszeski JM; Lippens G
J Biol Chem; 2010 Oct; 285(43):33435-33444. PubMed ID: 20679343
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer disease specific phosphoepitopes of Tau interfere with assembly of tubulin but not binding to microtubules.
Amniai L; Barbier P; Sillen A; Wieruszeski JM; Peyrot V; Lippens G; Landrieu I
FASEB J; 2009 Apr; 23(4):1146-52. PubMed ID: 19074508
[TBL] [Abstract][Full Text] [Related]
7. NMR spectroscopy of the neuronal tau protein: normal function and implication in Alzheimer's disease.
Landrieu I; Leroy A; Smet-Nocca C; Huvent I; Amniai L; Hamdane M; Sibille N; Buée L; Wieruszeski JM; Lippens G
Biochem Soc Trans; 2010 Aug; 38(4):1006-11. PubMed ID: 20658994
[TBL] [Abstract][Full Text] [Related]
8. Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5.
Baumann K; Mandelkow EM; Biernat J; Piwnica-Worms H; Mandelkow E
FEBS Lett; 1993 Dec; 336(3):417-24. PubMed ID: 8282104
[TBL] [Abstract][Full Text] [Related]
9. Role of Tau in Various Tauopathies, Treatment Approaches, and Emerging Role of Nanotechnology in Neurodegenerative Disorders.
Kaur P; Khera A; Alajangi HK; Sharma A; Jaiswal PK; Singh G; Barnwal RP
Mol Neurobiol; 2023 Mar; 60(3):1690-1720. PubMed ID: 36562884
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of human tau protein by microtubule-associated kinases: GSK3beta and cdk5 are key participants.
Flaherty DB; Soria JP; Tomasiewicz HG; Wood JG
J Neurosci Res; 2000 Nov; 62(3):463-72. PubMed ID: 11054815
[TBL] [Abstract][Full Text] [Related]
11. Tau therapeutic strategies for the treatment of Alzheimer's disease.
Churcher I
Curr Top Med Chem; 2006; 6(6):579-95. PubMed ID: 16712493
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.
Lovestone S; Reynolds CH; Latimer D; Davis DR; Anderton BH; Gallo JM; Hanger D; Mulot S; Marquardt B; Stabel S
Curr Biol; 1994 Dec; 4(12):1077-86. PubMed ID: 7704571
[TBL] [Abstract][Full Text] [Related]
13. Sulfhydration of AKT triggers Tau-phosphorylation by activating glycogen synthase kinase 3β in Alzheimer's disease.
Sen T; Saha P; Jiang T; Sen N
Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4418-4427. PubMed ID: 32051249
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Neuronal Tau Protein as a Target of Extracellular Signal-regulated Kinase.
Qi H; Prabakaran S; Cantrelle FX; Chambraud B; Gunawardena J; Lippens G; Landrieu I
J Biol Chem; 2016 Apr; 291(14):7742-53. PubMed ID: 26858248
[TBL] [Abstract][Full Text] [Related]
15. Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?
Leclerc S; Garnier M; Hoessel R; Marko D; Bibb JA; Snyder GL; Greengard P; Biernat J; Wu YZ; Mandelkow EM; Eisenbrand G; Meijer L
J Biol Chem; 2001 Jan; 276(1):251-60. PubMed ID: 11013232
[TBL] [Abstract][Full Text] [Related]
16. The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.
Jämsä A; Hasslund K; Cowburn RF; Bäckström A; Vasänge M
Biochem Biophys Res Commun; 2004 Jul; 319(3):993-1000. PubMed ID: 15184080
[TBL] [Abstract][Full Text] [Related]
17. Targeting Tau Hyperphosphorylation
Turab Naqvi AA; Hasan GM; Hassan MI
Curr Top Med Chem; 2020; 20(12):1059-1073. PubMed ID: 31903881
[TBL] [Abstract][Full Text] [Related]
18. Quantification of Methylation and Phosphorylation Stoichiometry.
Ayoub CA; Moore KI; Kuret J
Methods Mol Biol; 2024; 2754():221-235. PubMed ID: 38512670
[TBL] [Abstract][Full Text] [Related]
19. Isomerase Pin1 stimulates dephosphorylation of tau protein at cyclin-dependent kinase (Cdk5)-dependent Alzheimer phosphorylation sites.
Kimura T; Tsutsumi K; Taoka M; Saito T; Masuda-Suzukake M; Ishiguro K; Plattner F; Uchida T; Isobe T; Hasegawa M; Hisanaga SI
J Biol Chem; 2013 Mar; 288(11):7968-7977. PubMed ID: 23362255
[TBL] [Abstract][Full Text] [Related]
20. Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing.
Wen Y; Planel E; Herman M; Figueroa HY; Wang L; Liu L; Lau LF; Yu WH; Duff KE
J Neurosci; 2008 Mar; 28(10):2624-32. PubMed ID: 18322105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
